In addition, in vivo study results have demonstrated that PTX–CUR combination exhibited better efficacy in reducing mice mammary tumor size due to suppression of certain molecular markers, including protein kinase C, telomerase, NF-κB, and histone deacetylase in breast cancer mouse model [96]. Here, NFKB1 is linked to breast carcinoma.